This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Terumo Kabushiki Kaisha. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (2018)
- Sagamihara, JP (2019)
Company Filing History:
Years Active: 2018-2019
Title: Kenta Sakamoto: Innovator in Cell Culture Technology
Introduction
Kenta Sakamoto is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of cell culture technology, holding 2 patents that focus on innovative methods for producing and evaluating cell cultures. His work has implications for medical treatments and research.
Latest Patents
Sakamoto's latest patents include a "Method for producing sheet-shaped cell culture" and a "Method and system for evaluation of grafts." The first patent describes a method for creating a sheet-shaped cell culture that exhibits high activity and cytokine productivity. This method involves freezing and thawing cells to form a functional sheet-shaped culture, which can be used for treating diseases associated with tissue abnormalities. The second patent provides a method and system for evaluating the transplantation competence of graft samples containing cells capable of multinucleation. This method assesses the multinucleating ability of these cells as an indicator of their capacity for successful transplantation.
Career Highlights
Kenta Sakamoto is currently associated with Terumo Kabushiki Kaisha, a leading company in the medical technology sector. His work at Terumo has allowed him to focus on advancing cell culture techniques that can enhance therapeutic applications.
Collaborations
Sakamoto collaborates with Kouichirou Yori, contributing to the development of innovative solutions in the field of cell culture and transplantation.
Conclusion
Kenta Sakamoto's contributions to cell culture technology through his patents demonstrate his commitment to advancing medical science. His innovative methods have the potential to significantly impact the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
